GeneDx Holdings(WGS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

WGS GeneDx Holdings

Not Yet Opened 04-20 16:00:00 EDT

69.71

+3.75

+5.69%

盘后70.80

+1.09+1.57%

19:49 EDT

High70.32	Low65.55	Vol580.73K
Open65.96	D1 Closing65.96	Amplitude7.23%
Mkt Cap2.04B	Tradable Cap1.39B	Total Shares29.29M
T/O39.96M	T/O Rate2.91%	Tradable Shares19.94M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"WGS","market":"US","secType":"STK","nameCN":"GeneDx Holdings","latestPrice":69.71,"timestamp":1776715200000,"preClose":65.96,"halted":0,"volume":580732,"hourTrading":{"tag":"盘后","latestPrice":70.8012,"preClose":69.71,"latestTime":"19:49 EDT","volume":10199,"amount":712979.7565,"timestamp":1776728970457,"change":1.0912,"changeRate":0.015653,"amplitude":0.025963},"delay":0,"changeRate":0.05685263796240146,"floatShares":19944938,"shares":29288700,"eps":-0.733929,"marketStatus":"Not Yet Opened","change":3.75,"latestTime":"04-20 16:00:00 EDT","open":65.96,"high":70.3199,"low":65.55,"amount":39962009.84044,"amplitude":0.072315,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.733929,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1776758400000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":65.96,"preHourTrading":{"tag":"盘前","latestPrice":65.95,"preClose":65.96,"latestTime":"09:13 EDT","volume":1886,"amount":123421.16774399999,"timestamp":1776690827596,"change":-0.01,"changeRate":-0.000152,"amplitude":0.029867},"postHourTrading":{"tag":"盘后","latestPrice":70.8012,"preClose":69.71,"latestTime":"19:49 EDT","volume":10199,"amount":712979.7565,"timestamp":1776728970457,"change":1.0912,"changeRate":0.015653,"amplitude":0.025963},"volumeRatio":1.058568,"impliedVol":1.0413,"impliedVolPercentile":0.8048},"requestUrl":"/m/hq/s/WGS/wiki","defaultTab":"wiki","newsList":[{"id":"2629676727","title":"GeneDx Holdings Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2629676727","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629676727?lang=en_us&edition=fundamental","pubTime":"2026-04-21 00:32","pubTimestamp":1776702720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/WGS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 20, 2026 12:32 ET (16:32 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628295327","title":"GeneDx price target raised to $100 from $70 at Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2628295327","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628295327?lang=en_us&edition=fundamental","pubTime":"2026-04-20 21:59","pubTimestamp":1776693560,"startTime":"0","endTime":"0","summary":"Canaccord raised the firm’s price target on GeneDx (WGS) to $100 from $70 and keeps a Buy rating on the shares. The firm updated its model ahead of...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/genedx-price-target-raised-to-100-from-70-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/genedx-price-target-raised-to-100-from-70-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","WGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627216472","title":"Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2627216472","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627216472?lang=en_us&edition=fundamental","pubTime":"2026-04-16 21:15","pubTimestamp":1776345300,"startTime":"0","endTime":"0","summary":"SALT LAKE CITY, April  16, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced that it will share six abstracts, i","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/16/3275468/15459/en/Myriad-Genetics-to-Deliver-Six-Abstracts-Including-Two-Podiums-at-AACR-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYGN","BK4139","WGS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627413278","title":"U.S. RESEARCH ROUNDUP-Biogen, Equinix, Revolution Medicines","url":"https://stock-news.laohu8.com/highlight/detail?id=2627413278","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627413278?lang=en_us&edition=fundamental","pubTime":"2026-04-14 15:45","pubTimestamp":1776152709,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Biogen, Equinix, Revolution MedicinesApril 14 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Biog","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nL4N40X0LT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CPT","NEO","NSA","MSFL","AVB","CAG","CAI","BE","BSX","TREE","DLR","HUBS","LNG","PODD","MSFX","KHC","IDYA","GIS","MSFT","BIIB","ADPT","MKC","SJM","MAA","MRNA","JAN","MRNY","MSFO","INSP","MSFU","HSY","NTRA","EXR","ASAN","EQIX","GH","BRBR","CPB","MSFY","CUBE","BL","BEG","FLS","BDX","MRNX","ADGM","MSFD","WGS","BEX","CBRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627463265","title":"GeneDx to report first-quarter results after market close, host conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2627463265","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627463265?lang=en_us&edition=fundamental","pubTime":"2026-04-14 04:07","pubTimestamp":1776110824,"startTime":"0","endTime":"0","summary":"GeneDx schedules release of first-quarter fiscal 2026 financial results for May 4, 2026, following market close.Management plans conference call for May 4, 2026, at 4:30 p.m. ET.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genedx Holdings Corp. published the original content used to generate this news brief via Business Wire  on April 13, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nNDLbCQHNv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","WGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627843843","title":"MGI Tech Celebrates 10 Years of Innovation, Empowering 3,560 Users Across Six Continents","url":"https://stock-news.laohu8.com/highlight/detail?id=2627843843","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627843843?lang=en_us&edition=fundamental","pubTime":"2026-04-13 16:05","pubTimestamp":1776067500,"startTime":"0","endTime":"0","summary":"SHENZHEN, China, April 13, 2026 /PRNewswire/ -- MGI Tech Co., Ltd. , a company dedicated to developing core tools and technologies that drive innovation in life sciences, celebrates its 10th anniversary, a decade marked by breakthroughs that have helped transform genomics into a scalable, data-driven and accessible engine of discovery.Since its founding in 2016, MGI has tackled the fundamental challenges of making genomics affordable, scalable, and ready for real-world deployment. Providing trusted platforms for cutting-edge research and diagnostics, MGI serves over 3,560 users and 5,300 installations globally, contributing to 18,009 peer-reviewed publications to date. Now entering its second decade, the company is accelerating into the next chapter where artificial intelligence, integrated workflows, and multi-omics technologies converge to accelerate scientific discovery and real-world impact across medicine, agriculture, and environmental science.MGI's decade of progress is rooted i","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/mgi-tech-celebrates-10-years-of-innovation-empowering-3-560-users-across-six-continents-302740290.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4227","WGS","BK4196","LLM.AU","BK7095","BK4106","MGI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626650111","title":"Cathie Wood Buys the Dip in GeneDx (WGS): 142% Upside Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2626650111","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626650111?lang=en_us&edition=fundamental","pubTime":"2026-04-10 12:42","pubTimestamp":1775796150,"startTime":"0","endTime":"0","summary":"Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made notable portfolio moves on Thursday, April 9, as shown in ARK’s daily fund dis...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/cathie-wood-buys-the-dip-in-genedx-wgs-142-upside-ahead?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/cathie-wood-buys-the-dip-in-genedx-wgs-142-upside-ahead?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARKQ","ARKX","WGS","SARK","ARKW","ARKG","BK4196","ARKK","BK4588","ARKF","BK4585","BK4544"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625647931","title":"Assessing GeneDx Holdings (WGS) Valuation After Technical Weakness And Mixed Investor Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=2625647931","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625647931?lang=en_us&edition=fundamental","pubTime":"2026-04-05 23:19","pubTimestamp":1775402346,"startTime":"0","endTime":"0","summary":"GeneDx Holdings (WGS) recently drew attention after a 21% share price drop, as bearish technical signals, mixed analyst views, and institutional fund outflows contrasted with a more upbeat stance from some retail investors.\nSee our latest analysis for GeneDx Holdings.\nShort term momentum has been volatile, with a 1 day share price return of 1.04% and a 7 day gain of 15.96%, following a 30 day share price decline of 24.87% and a year to date share price return of 49.96% in the red. The 3 year...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-wgs/genedx-holdings/news/assessing-genedx-holdings-wgs-valuation-after-technical-weak","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-wgs/genedx-holdings/news/assessing-genedx-holdings-wgs-valuation-after-technical-weak","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["WGS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623417683","title":"GeneDx Holdings Is Maintained at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2623417683","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623417683?lang=en_us&edition=fundamental","pubTime":"2026-03-30 23:07","pubTimestamp":1774883220,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/WGS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 30, 2026 11:07 ET (15:07 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623312771","title":"GeneDx price target lowered to $100 from $170 at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2623312771","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623312771?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:51","pubTimestamp":1774871514,"startTime":"0","endTime":"0","summary":"Guggenheim analyst Subbu Nambi lowered the firm’s price target on GeneDx (WGS) to $100 from $170 and keeps a Buy rating on the shares. The firm adj...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/genedx-price-target-lowered-to-100-from-170-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/genedx-price-target-lowered-to-100-from-170-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["WGS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620261657","title":"A Look At GeneDx Holdings (WGS) Valuation After Ark Buying And Zevra Genetic Testing Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2620261657","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620261657?lang=en_us&edition=fundamental","pubTime":"2026-03-19 03:06","pubTimestamp":1773860818,"startTime":"0","endTime":"0","summary":"GeneDx Holdings (WGS) is back in focus after Ark Invest’s ETFs bought shares for seven straight trading days, alongside a new Niemann Pick disease type C genetic testing collaboration with Zevra Therapeutics.\nSee our latest analysis for GeneDx Holdings.\nDespite Ark’s buying streak and the new Zevra partnership, GeneDx’s share price has been under pressure, with a 30 day share price return of a 16.25% decline and a year to date share price return of a 42.93% decline, while the three year total...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-wgs/genedx-holdings/news/a-look-at-genedx-holdings-wgs-valuation-after-ark-buying-and","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-wgs/genedx-holdings/news/a-look-at-genedx-holdings-wgs-valuation-after-ark-buying-and","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4196","WGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618158347","title":"Cathie Wood Just Bought This Small Cap Stock Seven Days Straight: Should Investors Take Note?","url":"https://stock-news.laohu8.com/highlight/detail?id=2618158347","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618158347?lang=en_us&edition=fundamental","pubTime":"2026-03-12 23:07","pubTimestamp":1773328020,"startTime":"0","endTime":"0","summary":"Cathie Wood and Ark Invest have been snatching up shares of a small cap diagnostics company for seven straight days. Here's the stock.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/12/ARK-Invest-Photo-Cathie-Wood-3.png?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/12/ARK-Invest-Photo-Cathie-Wood-3.png?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/trading-ideas/long-ideas/26/03/51216368/cathie-wood-just-bought-this-small-cap-stock-seven-days-straight-should-investors-take-note","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/long-ideas/26/03/51216368/cathie-wood-just-bought-this-small-cap-stock-seven-days-straight-should-investors-take-note","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["ARKQ","ARKX","ARKG","BK4585","BK4588","WGS","BK4544","ARKW","ISBC","ARKK","BK4196","ARKF","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618132332","title":"Analysts’ Top Healthcare Picks: GeneDx Holdings (WGS), Zymeworks (ZYME)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618132332","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618132332?lang=en_us&edition=fundamental","pubTime":"2026-03-12 20:30","pubTimestamp":1773318622,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on GeneDx Holdings (WGS – Research Report) and Zymework...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-genedx-holdings-wgs-zymeworks-zyme-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-genedx-holdings-wgs-zymeworks-zyme-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","HCSG","XBI","BK4139","XLV","LU0128526141.USD","WGS","ZYME","BK4196","LABU","LU0029874061.USD","BK4585","BK4588","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618976452","title":"GeneDx SAVES-Kids study reports USD 80,000 average healthcare cost savings per child after exome and genome testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2618976452","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618976452?lang=en_us&edition=fundamental","pubTime":"2026-03-12 05:10","pubTimestamp":1773263447,"startTime":"0","endTime":"0","summary":"GeneDx reported results from its SAVES-Kids health economics analysis of whole exome and whole genome sequencing in children with neurodevelopmental disorders, including epilepsy and developmental delay or intellectual disability. The findings were presented at the ACMG Annual Meeting in Baltimore. In children with epilepsy, average total healthcare costs decreased 61% from USD 130,048 per patient per year before testing to USD 50,798 in the 12 months after testing. Among Medicaid-covered children with epilepsy, total healthcare costs decreased 53% in the year after testing, alongside 80% fewer hospitalizations. In children with developmental delay or intellectual disability, total healthcare costs decreased 19% in the first year after testing, with 80% fewer hospitalizations.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for information","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nNDL1MfGVF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WGS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618529958","title":"GeneDx to Launch Genetic Testing Program With Zevra Therapeutics to Support Patients With Suspected Niemann-Pick Disease Type C","url":"https://stock-news.laohu8.com/highlight/detail?id=2618529958","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618529958?lang=en_us&edition=fundamental","pubTime":"2026-03-10 20:33","pubTimestamp":1773145987,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nFWN3ZY0LS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["WGS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617505093","title":"Major Insider Moves at GeneDx Holdings Shake Up Investor Buzz","url":"https://stock-news.laohu8.com/highlight/detail?id=2617505093","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617505093?lang=en_us&edition=fundamental","pubTime":"2026-03-06 10:11","pubTimestamp":1772763095,"startTime":"0","endTime":"0","summary":"New insider activity at GeneDx Holdings ( ($WGS) ) has taken place on March 5, 2026. Recent insider activity at GeneDx Holdings has drawn attention...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-insider-moves-at-genedx-holdings-shake-up-investor-buzz-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-insider-moves-at-genedx-holdings-shake-up-investor-buzz-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["WGS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617706155","title":"Director and 10% Owner Keith A. Meister Acquires GeneDx Holdings Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2617706155","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617706155?lang=en_us&edition=fundamental","pubTime":"2026-03-06 08:20","pubTimestamp":1772756411,"startTime":"0","endTime":"0","summary":"Keith A. Meister, a director and 10% owner of GeneDx Holdings Corp., reported an acquisition of the company’s Class A common stock. The Form 4 was filed by Keith A. Meister, Corvex Management LP, and other reporting beneficial owners. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genedx Holdings Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 05, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nNDL5cFGL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Director and 10% Owner Keith A. Meister Acquires GeneDx Holdings Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WGS","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616325798","title":"REPROCELL Launches GMP Master Cell Bank Manufacturing for Clinical iPSCs","url":"https://stock-news.laohu8.com/highlight/detail?id=2616325798","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616325798?lang=en_us&edition=fundamental","pubTime":"2026-03-03 22:00","pubTimestamp":1772546400,"startTime":"0","endTime":"0","summary":"Integrated Workflow Including Clinical Seed Production and StemEdit Gene Editing Services. As part of this platform, the StemRNA Clinical iPSC Seed Clone – LLF-34-F3, derived from US sourced donor material, is supported by an active FDA Drug Master File . This clone has been expanded into a GMP MCB using FDA-compliant closed system processes. This off-the-shelf GMP iPSC MCB is now available for commercial use, providing ready-to-use clinically validated starting material. For sponsors requiring European alignment, REPROCELL also offers MCB/WCB manufacturing through its partner, Histocell. This service operates with a GMP certificate and authorization from the Spanish Agency for Medicines and Medical Devices  under European Medicines Agency  oversight.US-generated StemRNA Clinical Seed Clones supported by an active FDA DMF","market":"hk","thumbnail":"https://mma.prnewswire.com/media/2800592/REPROCELL_USA_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2800592/REPROCELL_USA_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/reprocell-launches-gmp-master-cell-bank-manufacturing-for-clinical-ipscs-302700233.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7129","EMA.AU","MCB","BK4081","BK4211","WGS","EMA","DMF","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616350258","title":"A Look At GeneDx Holdings (WGS) Valuation After Breakthrough Device Win And Upgraded 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2616350258","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616350258?lang=en_us&edition=fundamental","pubTime":"2026-03-03 01:25","pubTimestamp":1772472343,"startTime":"0","endTime":"0","summary":"GeneDx Holdings (WGS) has just put fresh numbers on the table, reporting its full year 2025 results along with reaffirmed 2026 revenue guidance and an FDA Breakthrough Device designation for its key genomic tests.\nSee our latest analysis for GeneDx Holdings.\nDespite strong 2025 results, reaffirmed 2026 revenue guidance and the FDA Breakthrough Device designation, GeneDx’s recent share price momentum has been weak, with a 30 day share price return of 17.19% and a 90 day share price return of...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-wgs/genedx-holdings/news/a-look-at-genedx-holdings-wgs-valuation-after-breakthrough-d","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-wgs/genedx-holdings/news/a-look-at-genedx-holdings-wgs-valuation-after-breakthrough-d","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["WGS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616313193","title":"GeneDx Holdings Corp - Secures $100 Mln Term Loan - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2616313193","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616313193?lang=en_us&edition=fundamental","pubTime":"2026-03-02 20:04","pubTimestamp":1772453045,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nFWN3ZQ0SX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","WGS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://ir.genedx.com","stockEarnings":[{"period":"1week","weight":0.1432},{"period":"1month","weight":-0.0019},{"period":"3month","weight":-0.3007},{"period":"6month","weight":-0.4239},{"period":"1year","weight":-0.2698},{"period":"ytd","weight":-0.464}],"compareEarnings":[{"period":"1week","weight":0.033},{"period":"1month","weight":0.0927},{"period":"3month","weight":0.046},{"period":"6month","weight":0.0613},{"period":"1year","weight":0.3463},{"period":"ytd","weight":0.0393}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It also provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. is headquartered in Stamford, Connecticut.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.104041},{"month":2,"riseRate":0.833333,"avgChangeRate":0.352675},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.143199},{"month":4,"riseRate":0.333333,"avgChangeRate":0.011647},{"month":5,"riseRate":0.4,"avgChangeRate":-0.013957},{"month":6,"riseRate":0.6,"avgChangeRate":0.029191},{"month":7,"riseRate":0.8,"avgChangeRate":0.138059},{"month":8,"riseRate":0.2,"avgChangeRate":-0.136267},{"month":9,"riseRate":0.2,"avgChangeRate":-0.072401},{"month":10,"riseRate":0.8,"avgChangeRate":0.18872},{"month":11,"riseRate":0.2,"avgChangeRate":-0.130294},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.04765}],"exchange":"NASDAQ","name":"GeneDx Holdings","nameEN":"GeneDx Holdings"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GeneDx Holdings(WGS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GeneDx Holdings(WGS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GeneDx Holdings,WGS,GeneDx Holdings股票,GeneDx Holdings股票老虎,GeneDx Holdings股票老虎国际,GeneDx Holdings行情,GeneDx Holdings股票行情,GeneDx Holdings股价,GeneDx Holdings股市,GeneDx Holdings股票价格,GeneDx Holdings股票交易,GeneDx Holdings股票购买,GeneDx Holdings股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GeneDx Holdings(WGS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GeneDx Holdings(WGS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}